Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by moderate_drumbowsion Jan 05, 2013 5:55pm

285 Views

Post# 20802106

RE: Shorting

Nyguy, very obnoxious post, particularly ytrying to rub it in peoples faces with comments such as those that bought at 4 thanks. Personally I am hopeful that the stock gets more good news and that you get yours handed to you. I do not typically wish bad things on people but for obnoxious pr icks such as you I have made an exception. Capiche?

Cheers

Drumbo

Bullboard Posts

Desert Gold Ventures - A jewel for the investor?